Project Number 5R01AG048349-02 Agency/Funding Organization NIA Funding Year 2016 View Full Project Details for PHASE II/III TRIAL FOR SLOWING PROGRESSION IN MILD COGNITIVE IMPAIRMENT Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 8. Late-stage Clinical Drug Development (Phase II/III and III Clinical Trials) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator GALLAGHER, MICHELA Principal Investigator First Name MICHELA Principal Investigator Last Name GALLAGHER Awardee Organization JOHNS HOPKINS UNIVERSITY Awardee State Maryland Contact PI Country United States Project Detail Funding Opportunity Announcement PA-13-302: RESEARCH PROJECT GRANT (PARENT R01) FY Overall Cost $1,668,503 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M Related Resources Clinical Trial Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease
